Skip to main content
Clinical Trials/CTRI/2023/05/053006
CTRI/2023/05/053006
Not yet recruiting
Phase 2

Clinical study to evaluate the efficacy of vidanga churna in the management of Urdhwaga Amlapitta due to Helicobacter pylori.

Dr S Maniziia0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K296- Other gastritis
Sponsor
Dr S Maniziia
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr S Maniziia

Eligibility Criteria

Inclusion Criteria

  • 1\.Sour or bitter eructation/belching
  • 2\.nausea, pyrosis, water brash,
  • 3\.Indigestion,Loss of appetite
  • 4\.Gaseous distension, heaviness of body
  • 5\.Positive Helicobacter pylori in upper GI endoscopy yr

Exclusion Criteria

  • 1\.Any Cancer of Gastrointestinal tract
  • 2\.Past history of Abdominal surgery
  • 3\.Pregnant and lactating mother
  • 4\.Patients of major systemic illness including Cardiac, hepatobiliary, kidney and IBS
  • 5\.Hiatus hernia
  • 6\.Major Oral pharyngeal and laryngeal infections

Outcomes

Primary Outcomes

Not specified

Similar Trials